Vectored immunotherapy sustains long-term HIV suppression after antiretroviral therapy interruption 2257591
HIV persists as a pandemic to this day, and although current antiretroviral therapies (ART) are effective, their success relies on strict adherence to the treatment. Broadly neutralizing antibodies (bNAbs) have also been evaluated as a therapeutic approach, but their implementation is undermined by the need for r...